Phoenix PharmaLabs
Addressing the opioid crisis by developing potent, safe, non-addictive painkillers.
Analytics
Raised to Date: $903,558
Aggregate Commitments $
Platform
Netcapital
Start Date
01/31/2021
Close Date
06/18/2021
Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment
$99
Security Type
Equity - Common
Funding Type
RegCF
Series
Seed
Pre-Money Valuation
$26,790,283
Rolling Commitments $
Status
Active
Reporting Date
06/09/2021
Days Remaining
6
% of Min. Goal
9,036%
% of Max. Goal
84%
Likelihood of Max
Avg. Daily Raise
$7,004
Momentum
Log in or create a free account today to gain access to KingsCrowd analytics.
Founder Profile
Location
Woods Cross, Utah
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B2C
Margin
High
Capital Intensity
High
Phoenix PharmaLabs, with a post-money valuation of $26,790,283, is Crowdfunding on NetCapital. The company is a preclinical drug discovery company dedicated to the development of potent, safe, non-addictive treatments for pain and addiction. John Lawson, PH.D. and Lawrence Toll, PH.D. founded Phoenix PharmaLabs. The crowdfunding round has a minimum raise of $10,000 and a maximum raise of $1,070,000. Phoenix PharmaLabs lead drug, PPL-103, has demonstrated in animal studies that it is a very potent painkiller (10x more potent than morphine), and is non-addictive, does not produce withdrawal, does not cause death from overdose at elevated doses, and causes no constipation.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$1,285,068 |
$66,654 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$100 |
| ||
| ||
|
Net Income |
$-552,876 |
$-939,817 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$761,206 |
$37,344 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$761,206 |
$37,344 |
|
Short-Term Debt |
$0 |
$1,964,449 |
|
Long-Term Debt |
$2,058,665 |
$0 |
|
Total Liabilities |
$2,058,665 |
$1,964,449 |
Log in or create a free account today to gain access to KingsCrowd analytics.
Summary of Crowdfunding Raises
| Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Phoenix PharmaLabs | 06/18/2021 | Netcapital | $26,790,283 | $903,558 | Equity - Common | Active | RegCF |
| Phoenix PharmaLabs | 01/30/2021 | Netcapital | $26,790,283 | $0 | Equity - Common | Funded | Test the Waters |
| Phoenix PharmaLabs | 03/30/2019 | Netcapital | $23,136,335 | $1,102,553 | Equity - Common | Funded | RegCF |
Log in or create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$8.33 /month
billed annually - Free portfolio tracking. Limited reports and filters.
- Plan Includes:
- Everything in Free, plus
- Advanced company search ( limited filters)
- Founder profiles and exclusive webinars
- 2 Analyst Reports per month
- Get Starter Annual
Starter
-
$25 /month
billed annually - Unlimited analyst reports and market analytics.
- Plan Includes:
- Everything in Starter, plus
- Full access to all Analyst Reports
- Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
- Market Analytics
- Get Pro Annual
Pro
-
$41.67 /month
billed annually - Full site access including Merlin ratings.
- Plan Includes:
- Everything in Pro, plus
- Search and filter companies by Merlin ratings
- Company specific
Merlin rating and risk assessment
- Get Merlin Annual
Merlin
Already a member? Log in here.
Other Deals
Hidden Company on Platform
Analyst reports are restricted for only Pro and Merlin members. Please upgrade for access.
Hidden Company on Platform
Analyst reports are restricted for only Pro and Merlin members. Please upgrade for access.
Hidden Company on Platform
Analyst reports are restricted for only Pro and Merlin members. Please upgrade for access.